Previous 10 | Next 10 |
The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2020 Q1 earnings Read more ...
TFF Pharmaceuticals, Inc. (TFFP) Q1 2020 Earnings Conference Call May 14, 2020 5:00 PM ET Company Participants Paul Sagan – Investor Relations Glenn Mattes – President and Chief Executive Officer Kirk Coleman – Chief Financial Officer Chris Cano – Vi...
TFF Pharmaceuticals (NASDAQ: TFFP ): Q1 GAAP EPS of -$0.20 beats by $0.04 . Cash and cash equivalents of $25.73M Press Release More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,
Maintains clinical progress with lead programs, Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder Thin Film Freezing platform technology employed in numerous partnership programs for vaccine and anti-viral applications Conference call and live webcast scheduled for T...
Company to hold conference call and webcast at 5:00 PM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today a...
Data presented on repurposing the existing, broad-spectrum antiviral agent using Thin Film Freezing and other techniques to enhance its effect for COVID-19 therapy TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercial...
The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with this Read more ...
One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, plans to raise $75 million at a $424 million market cap. The...
There were no IPOs this past week, but initial filings from a biotech and a Chinese issuer are keeping the IPO market moving. After another strong week, the IPO Index is now up about 35% from its March lows. As we pointed out in our 1Q20 IPO Review, the first IPOs to emerge from the shutdown...
Corporate presentation and live webcast scheduled for April 22, 2020 at 10:00am ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) tech...
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NASDAQ Market:
TFF Pharmaceuticals Inc - Ordinary Shares Website:
FORT WORTH, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FDA Provided Constructive Feedback to Help Guide Next Steps in TFF TAC Clinical Development Company to Provide More Detailed Regulatory Update in 3Q 2024 FORT WORTH, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a ...